Watson Pharmaceuticals Invests in $15M New Jersey Expansion
05/27/2010
"Over the past year, we have outgrown our current administrative headquarters site, as our U.S. and global business has rapidly grown," said Paul Biscaro, Watson president and CEO. "This new facility will ensure that we have a single location for the leadership and shared services functions that are driving our global growth."
New Jersey's Business Employment Incentive Program (BEIP) has extended Watson a grant of approximately $7.3 million over the next 10 years from the state's Economic Development Authority. It has also been approved for a $290,000 Business Retention and Relocation Assistance Grant (BRRAG) to retain 200 jobs in New Jersey.
Watson was the country's third largest producer of generic drugs in 2009 based on prescriptions dispensed. It specializes in drugs for urology and women's health.
Project Announcements
La Colombe Coffee Roasters Expands Norton Shores, Michigan, Operations
02/23/2026
GRVTY Plans Tysons, Virginia, Headquarters Operations
02/23/2026
Hudson Industries Expands Appleton City, Missouri, Operations
02/23/2026
Israel-Based Katz 1899 Plans Dayton, Ohio, Manufacturing Operations
02/23/2026
Chick-fil-A Supply Plans Winter Haven, Florida, Logistics-Distribution Operations
02/17/2026
Annandale Millwork and Allied Systems Plans Newport News, Virginia, Operations
02/17/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025